MURANO To Drive AbbVie/Roche's Venetoclax In CLL
Top-line MURANO data support Venclexta's current conditional approvals and expand its use into a broader population that should radically boost sales.
Top-line MURANO data support Venclexta's current conditional approvals and expand its use into a broader population that should radically boost sales.